Abstract:
Identifying babies with critical cardiac defects as early as possible is crucial for their survival and long-term wellbeing. A pulse oximeter is a device that can determine the oxygen level in the blood and has been successfully utilised internationally to aid in the early diagnosis of cardiac defects. New Zealand has a largely midwifery-lead model of maternity care and will face unique challenges when implementing a new screening practice. The feasibility of a nationwide screening programme should be investigated prior to adopting this practice at national level.
